Browsing by Author : Do, Young Rok
Showing results 1 to 60 of 182
-
1
Article
A Case of Double-unit Cord Blood Transplantation in Primary Refractory Acute Myeloid Leukemia
김진영
;
박건욱
;
도영록
2014
-
2
Article
A Case of Floral Variant of Follicular Lymphoma
김진영
;
도영록
;
박건욱
;
et al
2011
-
3
Article
A Case of Pneumatosis Intestinalis in Ph+ Acute Lymphoblastic Leukemia
김진영
;
박건욱
;
송홍석
;
et al
2012
-
4
Article
A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma
도영록
2011
-
5
Article
A Long-Term Survival Case of Primary Angiosarcoma in Liver Treated with Weekly Docetaxel Chemotherapy
김진영
;
도영록
;
박건욱
;
et al
2011
-
6
Article
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study
도영록
2023
-
7
Article
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study
도영록
2023
-
8
Article
A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer
김진영
;
도영록
;
박건욱
;
et al
2010
-
9
Article
A Multi-Center, Phase II Clinical T rial of PadexolTM (Paclitaxel) and Cisplatin for Patients Suffering w ith A dvanced Gastric Cancer
도영록
;
송홍석
;
박건욱
2005
-
10
Article
A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment
도영록
2022
-
11
Article
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea
도영록
2018
-
12
Article
A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer
도영록
;
송홍석
;
권기영
2008
-
13
Article
A phase II study of biweekly irinotecan plus cisplatin in patients with extensive stage small lung cancer
권기영
;
도영록
;
송홍석
;
et al
2008
-
14
Article
A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
송홍석
;
도영록
2008
-
15
Article
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma
도영록
2020
-
16
Article
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis
도영록
2020
-
17
Article
A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)
도영록
2019
-
18
Article
A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome
도영록
2015
-
19
Article
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
도영록
2017
-
20
Article
A retrospective analysis of etiology and outcomes of hemophagocytic lymphohistiocytosis in children and adults
정난이
;
심예지
;
김흥식
;
et al
2021
-
21
Article
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
도영록
2018
-
22
Article
Acute promyelocytic leukemia with submicroscopic deletion of 3'-region of PML on derivative chromosome 17
김재룡
;
김진영
;
송홍석
;
et al
2008
-
23
Article
Adrenalectomy for Metastatic Disease to the Adrenal Gland from Gastric Cancer: Report of a Case
도영록
;
송홍석
;
김인호
2007
-
24
Article
Adriamycin에 의해 유발된 가역적인 심근병증 1례
도영록
;
송홍석
;
조주연
2002
-
25
Article
Adult T-cell leukemia/lymphoma with CLL-like morphology
김도훈
;
하정숙
;
도영록
2011
-
26
Article
Apoptosis of K562 leukemia cells by Abnobaviscum F®, a European mistletoe extract
장병철
;
도영록
2012
-
27
Article
Appropriate Starting Dose of Dasatinib Based on Analyses of Dose-Limiting Toxicities and Molecular Responses in Asian Patients With Chronic Myeloid Leukemia
도영록
2021
-
28
Article
Attitudes toward early palliative care in cancer patients and caregivers: a Korean nationwide survey.
도영록
2018
-
29
Article
Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study
도영록
2020
-
30
Article
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
도영록
2018
-
31
Article
Bilateral sequential audiovestibular loss as an initial manifestation of chronic myelogenous leukemia
김현아
;
이현아
;
이형
;
et al
2014
-
32
Article
Biweekly Irinotecan and Cisplatin as Second-line Chemotherapy in Pretreated Patients with Advanced Gastric Cancer: A Multicenter Phase II Study
송홍석
;
권기영
;
도영록
;
et al
2005
-
33
Article
Bone Marrow and Multiple Extra-Pulmonary Relapses of Pulmonary Marginal Zone B-cell Lymphoma - A Case Report
김진영
;
도영록
;
박건욱
;
et al
2010
-
34
Article
Bortezomib and the Increased Incidence of Herpes Zoster
in Patients with Multiple Myeloma
도영록
2008
-
35
Article
Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)
도영록
2010
-
36
Article
Burdens, Needs and Satisfaction of Terminal Cancer Patients and their Caregivers
도영록
2013
-
37
Article
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
도영록
2023
-
38
Article
Busulfan, Melphalan, and Etoposide (Bume) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High Risk Non-Hodgkin's Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL)
도영록
2023
-
39
Article
Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study bythe Consortium for Improving Survival of Lymphoma (CISL)
도영록
2023
-
40
Article
c-kit Expression and mutations in peripheral T cell lymphomas, except for extra-nodal NK/T cell lymphomas
도영록
;
권기영
;
송홍석
2006
-
41
Article
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial
도영록
2021
-
42
Article
Changes in health-related quality of life and quality of care among terminally ill cancer patients and survival prediction: Multicenter prospective cohort study.
도영록
2015
-
43
Article
Clinical characteristics and prognostic factors of acquired haemophilia A in Korea
도영록
2021
-
44
Article
Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study
심예지
;
김흥식
;
도영록
2020
-
45
Article
Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era
도영록
2024
-
46
Article
Clinical Features and Survival of Patients With Follicular Lymphoma in Korea
도영록
2016
-
47
Article
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry
도영록
2009
-
48
Article
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone
도영록
2020
-
49
Article
Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma
도영록
2016
-
50
Article
Clinical Outcome and Prognosis of Patients with Primary Sinonasal Tract Diffuse Large B Cell Lymphoma Treated with R-CHOP Chemotherapy; A Study by the Consortium for Improving Survival for Lymphoma
도영록
2015
-
51
Article
Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement
김진영
;
도영록
;
박건욱
;
et al
2013
-
52
Article
Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter
Observational Study in Korea
도영록
2014
-
53
Article
Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas
도영록
;
권기영
;
송홍석
2006
-
54
Article
Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in de novo diffuse large B-cell lymphoma: a multicenter retrospective study
도영록
2024
-
55
Article
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial
도영록
2024
-
56
Article
Comparison of attitudes towards five end-of-life care interventions (active pain control, withdrawal of futile lifesustaining treatment, passive euthanasia, active euthanasia and physician-assisted suicide): a multicentred cross-sectional survey of Korean patients with cancer, their family caregivers, physicians and the general Korean population
도영록
2018
-
57
Article
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
도영록
2023
-
58
Article
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant ChronicePhase Chronic Myeloid Leukemia
도영록
2018
-
59
Article
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia
도영록
2021
-
60
Article
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.
도영록
2017